Aghajanian CA - Search Results

1

Role of pegylated liposomal doxorubicin in ovarian cancer.

Thigpen JT, Aghajanian CA, Alberts DS, Campos SM, Gordon AN, Markman M, McMeekin DS, Monk BJ, Rose PG. Thigpen JT, et al. Among authors: aghajanian ca. Gynecol Oncol. 2005 Jan;96(1):10-8. doi: 10.1016/j.ygyno.2004.09.046. Gynecol Oncol. 2005. PMID: 15589573 Review.

2

Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.

Barakat RR, Sabbatini P, Bhaskaran D, Revzin M, Smith A, Venkatraman E, Aghajanian C, Hensley M, Soignet S, Brown C, Soslow R, Markman M, Hoskins WJ, Spriggs D. Barakat RR, et al. J Clin Oncol. 2002 Feb 1;20(3):694-8. doi: 10.1200/JCO.2002.20.3.694. J Clin Oncol. 2002. PMID: 11821450

3

Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series.

Pothuri B, Vaidya A, Aghajanian C, Venkatraman E, Barakat RR, Chi DS. Pothuri B, et al. Gynecol Oncol. 2003 May;89(2):306-13. doi: 10.1016/s0090-8258(03)00073-8. Gynecol Oncol. 2003. PMID: 12713996

4

Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy.

Leitao MM Jr, Hummer A, Dizon DS, Aghajanian C, Hensley M, Sabbatini P, Venkatraman E, Spriggs DR. Leitao MM Jr, et al. Gynecol Oncol. 2003 Oct;91(1):123-9. doi: 10.1016/s0090-8258(03)00464-5. Gynecol Oncol. 2003. PMID: 14529671

5

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.

Dizon DS, Dupont J, Anderson S, Sabbatini P, Hummer A, Aghajanian C, Spriggs D. Dizon DS, et al. Gynecol Oncol. 2003 Dec;91(3):584-90. doi: 10.1016/j.ygyno.2003.08.017. Gynecol Oncol. 2003. PMID: 14675681

6

Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer.

Prasad M, Ben-Porat L, Hoppe B, Aghajanian C, Sabbatini P, Chi DS, Hensley ML. Prasad M, et al. Gynecol Oncol. 2004 Apr;93(1):223-8. doi: 10.1016/j.ygyno.2004.01.014. Gynecol Oncol. 2004. PMID: 15047240

7

Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma.

Krychman ML, Carter J, Aghajanian CA, Dizon DS, Castiel M. Krychman ML, et al. Among authors: aghajanian ca. Gynecol Oncol. 2004 May;93(2):561-3. doi: 10.1016/j.ygyno.2004.02.001. Gynecol Oncol. 2004. PMID: 15099982

8

Weekly topotecan for recurrent endometrial cancer: a case series and review of the literature.

Traina TA, Sabbatini P, Aghajanian C, Dupont J. Traina TA, et al. Gynecol Oncol. 2004 Oct;95(1):235-41. doi: 10.1016/j.ygyno.2004.07.035. Gynecol Oncol. 2004. PMID: 15385138 Review.

9

Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.

Hensley ML, Correa DD, Thaler H, Wilton A, Venkatraman E, Sabbatini P, Chi DS, Dupont J, Spriggs D, Aghajanian C. Hensley ML, et al. Gynecol Oncol. 2006 Aug;102(2):270-7. doi: 10.1016/j.ygyno.2005.12.042. Epub 2006 Feb 20. Gynecol Oncol. 2006. PMID: 16490239 Clinical Trial.

10

The role of bevacizumab in ovarian cancer--an evolving story.

Aghajanian C. Aghajanian C. Gynecol Oncol. 2006 Aug;102(2):131-3. doi: 10.1016/j.ygyno.2006.06.014. Gynecol Oncol. 2006. PMID: 16846774 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters